Opioids in chronic non‐cancer pain: systematic review of efficacy and safety

By E. Kalso, J. Edwards, A. Moore, Henry McQuay. Pain, 2004

1,201 citations recorded by the source corpus.

Subfields: Anesthesiology and Pain Medicine, Physiology, Public Health, Environmental and Occupational Health

View Paper: https://www.semanticscholar.org/paper/6558a9f6b9ce30f988a1eaa8f3bfcb1b637cb75d

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Anesthesiology and Pain Medicine

1. Angelie Singh
2. L. Manchikanti

In Public Health, Environmental and Occupational Health

1. Angelie Singh
2. L. Manchikanti

Citations in the corpus

• What Is New in Rome IV (2017, background): “It has a prevalence of 41% in patients with chronic non-cancer pain, and up to 94% of patients taking opioids for cancer-related pain.(60) Initial treatment of OIC is similar to that of functional constipation including laxatives and lubiprostone has been approved by FDA for patients with OIC in pat”
• Clinical Guidelines for the Use of Chronic Opioid Therapy in Chronic Noncancer Pain (2009, neutral): “The medical home model does not necessarily require the primary care clinician to prescribe and monitor COT.”
• Opioid complications and side effects. (2008, background): “Currently, statistics show that approximately 90% of patients with chronic pain receive opioids (3-26), and 90% of patients presenting to an interventional pain management center are already on opioids (27).”
• Therapeutic opioids: a ten-year perspective on the complexities and complications of the escalating use, abuse, and nonmedical use of opioids. (2008, background): “Kalso et al (63) concluded that the mean decrease in pain intensity in most studies was at least 30% and at least 44% of the patients continued treatment between 7 and 24 months.”
• Challenges in Using Opioids to Treat Pain in Persons With Substance Use Disorders (2008, neutral): “…approach both reduces pain and may foster modest improvements in function and quality of life (Devulder, Richarz, and Nataraja, 2005; Haythornthwaite et al., 1998; Kalso et al., 2004; Martell et al., 2007; Noble et al., 2008; Passik et al., 2005; Portenoy et al., 2007; Portenoy and Foley, 1986).”